Celldex Therapeutics Inc (CLDX)
39.63
+1.03
(+2.67%)
USD |
NASDAQ |
Apr 17, 16:00
40.30
+0.67
(+1.69%)
Pre-Market: 08:35
Celldex Therapeutics Total Assets (Quarterly): 465.63M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 465.63M |
| September 30, 2023 | 280.26M |
| June 30, 2023 | 299.31M |
| March 31, 2023 | 324.52M |
| December 31, 2022 | 352.74M |
| September 30, 2022 | 369.23M |
| June 30, 2022 | 402.96M |
| March 31, 2022 | 424.04M |
| December 31, 2021 | 444.65M |
| September 30, 2021 | 460.20M |
| June 30, 2021 | 204.55M |
| March 31, 2021 | 219.06M |
| December 31, 2020 | 235.84M |
| September 30, 2020 | 255.77M |
| June 30, 2020 | 261.40M |
| March 31, 2020 | 112.50M |
| December 31, 2019 | 122.93M |
| September 30, 2019 | 131.84M |
| June 30, 2019 | 142.24M |
| March 31, 2019 | 147.58M |
| December 31, 2018 | 155.81M |
| September 30, 2018 | 168.29M |
| June 30, 2018 | 178.38M |
| March 31, 2018 | 191.38M |
| December 31, 2017 | 315.62M |
| Date | Value |
|---|---|
| September 30, 2017 | 319.42M |
| June 30, 2017 | 346.07M |
| March 31, 2017 | 360.05M |
| December 31, 2016 | 383.36M |
| September 30, 2016 | 251.95M |
| June 30, 2016 | 271.21M |
| March 31, 2016 | 301.93M |
| December 31, 2015 | 337.58M |
| September 30, 2015 | 352.63M |
| June 30, 2015 | 383.22M |
| March 31, 2015 | 407.70M |
| December 31, 2014 | 248.01M |
| September 30, 2014 | 271.66M |
| June 30, 2014 | 297.59M |
| March 31, 2014 | 318.70M |
| December 31, 2013 | 347.10M |
| September 30, 2013 | 180.96M |
| June 30, 2013 | 196.23M |
| March 31, 2013 | 224.36M |
| December 31, 2012 | 125.54M |
| September 30, 2012 | 119.84M |
| June 30, 2012 | 122.13M |
| March 31, 2012 | 136.74M |
| December 31, 2011 | 97.99M |
| September 30, 2011 | 108.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
112.50M
Minimum
Mar 2020
465.63M
Maximum
Dec 2023
289.98M
Average
280.26M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | 11.23M |
| Perspective Therapeutics Inc | 97.89M |
| Electromed Inc | 46.96M |
| Xtant Medical Holdings Inc | 92.61M |
| Asensus Surgical Inc | 59.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.46M |
| Shareholders Equity (Quarterly) | 429.17M |
| Current Ratio | 13.87 |